Legacy Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $5.85M | Buy |
80,143
+750
| +0.9% | +$50.4K | 1.93% | 12 |
|
|
2021
Q4 | $4.95M | Sell |
79,393
-1,765
| -2% | -$104K | 1.6% | 19 |
|
|
2021
Q3 | $4.8M | Sell |
81,158
-1,113
| -1% | -$73.3K | 1.74% | 17 |
|
|
2021
Q2 | $5.5M | Buy |
82,271
+3,695
| +5% | +$241K | 1.97% | 12 |
|
|
2021
Q1 | $4.96M | Buy |
78,576
+23,756
| +43% | +$1.48M | 1.87% | 14 |
|
|
2020
Q4 | $3.4M | Sell |
54,820
-5,495
| -9% | -$338K | 1.33% | 21 |
|
|
2020
Q3 | $3.64M | Buy |
60,315
+3,050
| +5% | +$184K | 1.47% | 19 |
|
|
2020
Q2 | $3.37M | Buy |
57,265
+556
| +1% | +$33.3K | 1.45% | 20 |
|
|
2020
Q1 | $3.16M | Sell |
56,709
-2,635
| -4% | -$161K | 1.57% | 18 |
|
|
2019
Q4 | $3.81M | Buy |
59,344
+15,582
| +36% | +$892K | 1.54% | 19 |
|
|
2019
Q3 | $2.22M | Buy |
43,762
+15,685
| +56% | +$737K | 0.97% | 39 |
|
|
2019
Q2 | $1.27M | Buy |
28,077
+20,045
| +250% | +$934K | 0.57% | 57 |
|
|
2019
Q1 | $383K | Hold |
8,032
| – | – | 0.18% | 97 |
|
|
2018
Q4 | $418K | Hold |
8,032
| – | – | 0.22% | 91 |
|
|
2018
Q3 | $499K | Sell |
8,032
-100
| -1% | -$5.93K | 0.23% | 85 |
|
|
2018
Q2 | $450K | Sell |
8,132
-2,600
| -24% | -$140K | 0.22% | 87 |
|
|
2018
Q1 | $679K | Sell |
10,732
-11
| -0.1% | -$708 | 0.34% | 73 |
|
|
2017
Q4 | $658K | Sell |
10,743
-1
| -0% | -$63 | 0.33% | 66 |
|
|
2017
Q3 | $685K | Buy |
10,744
+662
| +7% | +$38.7K | 0.36% | 67 |
|
|
2017
Q2 | $562K | Buy |
10,082
+339
| +3% | +$18.4K | 0.3% | 73 |
|
|
2017
Q1 | $530K | Buy |
9,743
+1,611
| +20% | +$88.4K | 0.3% | 72 |
|
|
2016
Q4 | $476K | Buy |
8,132
+1,650
| +25% | +$90.2K | 0.29% | 76 |
|
|
2016
Q3 | $350K | Sell |
6,482
-2,000
| -24% | -$128K | 0.22% | 92 |
|
|
2016
Q2 | $624K | Sell |
8,482
-368
| -4% | -$26K | 0.39% | 67 |
|
|
2016
Q1 | $566K | Sell |
8,850
-400
| -4% | -$25.2K | 0.36% | 70 |
|
|
2015
Q4 | $637K | Hold |
9,250
| – | – | 0.41% | 66 |
|
|
2015
Q3 | $548K | Sell |
9,250
-1,000
| -10% | -$63.4K | 0.37% | 73 |
|
|
2015
Q2 | $683K | Sell |
10,250
-100
| -1% | -$6.59K | 0.44% | 69 |
|
|
2015
Q1 | $668K | Sell |
10,350
-200
| -2% | -$12.5K | 0.43% | 68 |
|
|
2014
Q4 | $623K | Hold |
10,550
| – | – | 0.4% | 70 |
|
|
2014
Q3 | $540K | Hold |
10,550
| – | – | 0.36% | 70 |
|
|
2014
Q2 | $512K | Hold |
10,550
| – | – | 0.33% | 73 |
|
|
2014
Q1 | $549K | Sell |
10,550
-200
| -2% | -$10.6K | 0.39% | 70 |
|
|
2013
Q4 | $572K | Hold |
10,750
| – | – | 0.41% | 66 |
|
|
2013
Q3 | $498K | Sell |
10,750
-25
| -0.2% | -$1.1K | 0.37% | 70 |
|
|
2013
Q2 | $482K | Buy |
+10,775
| New | +$468K | 0.37% | 68 |
|
Other funds holding BMY
Legacy Capital Partners's BMY Position: Q1 2022 in Review
Legacy Capital Partners increased its Bristol-Myers Squibb (BMY) stake by 0.94% in Q1 2022, buying an estimated $50.4K and bringing the position to 80,143 shares worth $5.85M. The position accounts for 1.93% of the portfolio, ranked #12.
Legacy Capital Partners first reported a position in BMY in Q2 2013 and has held it in 36 quarters since. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.
- Legacy Capital Partners held 80,143 shares of Bristol-Myers Squibb worth $5.85M as of Q1 2022.
- Legacy Capital Partners bought 750 Bristol-Myers Squibb shares in Q1 2022, an estimated $50.4K.
- Bristol-Myers Squibb made up 1.93% of Legacy Capital Partners's portfolio in Q1 2022, its #12 holding.
- Legacy Capital Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 36 quarters since.
- 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.
Based on Legacy Capital Partners's 13F filing for Q1 2022, filed 11 Apr 2022.